Back to top
more

Fortrea Holdings Inc. (FTRE)

(Delayed Data from NSDQ)

$19.26 USD

19.26
2,653,824

+0.76 (4.11%)

Updated Dec 20, 2024 04:00 PM ET

After-Market: $19.26 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.35%
2Buy18.11%
3Hold9.74%
4Sell5.34%
5Strong Sell2.80%
S&P50011.41%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 26% (65 out of 249)

Industry: Medical - Biomedical and Genetics

Zacks News

Fortrea Holdings Inc. (FTRE) Lags Q3 Earnings Estimates

Fortrea Holdings Inc. (FTRE) delivered earnings and revenue surprises of -14.81% and 0.12%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Puma Biotech (PBYI) Q3 Earnings and Revenues Surpass Estimates

Puma Biotech (PBYI) delivered earnings and revenue surprises of 28.57% and 12.88%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Acadia Pharmaceuticals (ACAD) Beats Q3 Earnings and Revenue Estimates

Acadia (ACAD) delivered earnings and revenue surprises of 53.85% and 0.46%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Will BioXcel Therapeutics, Inc. (BTAI) Report Negative Q3 Earnings? What You Should Know

BioXcel Therapeutics (BTAI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Fortrea Holdings Inc. (FTRE) Reports Next Week: Wall Street Expects Earnings Growth

Fortrea Holdings Inc. (FTRE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Blueprint Medicines (BPMC) Reports Q3 Loss, Tops Revenue Estimates

Blueprint Medicines (BPMC) delivered earnings and revenue surprises of 8.25% and 1.56%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Do Options Traders Know Something About Fortrea Holdings (FTRE) Stock We Don't?

Investors need to pay close attention to Fortrea Holdings (FTRE) stock based on the movements in the options market lately.

Fortrea Holdings Inc. (FTRE) Reports Q2 Loss, Lags Revenue Estimates

Fortrea Holdings Inc. (FTRE) delivered earnings and revenue surprises of -142.86% and 3.45%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

InflaRx N.V. (IFRX) Reports Q2 Loss, Lags Revenue Estimates

InflaRx (IFRX) delivered earnings and revenue surprises of -23.81% and 83%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Caribou Biosciences, Inc. (CRBU) May Report Negative Earnings: Know the Trend Ahead of Q2 Release

Caribou Biosciences (CRBU) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Fortrea Holdings Inc. (FTRE) Q2 Earnings Expected to Decline

Fortrea Holdings Inc. (FTRE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Ensign Group (ENSG) Q2 Earnings and Revenues Top Estimates

Ensign Group (ENSG) delivered earnings and revenue surprises of 2.33% and 1.97%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Do Options Traders Know Something About Fortrea (FTRE) Stock We Don't?

Investors need to pay close attention to Fortrea (FTRE) stock based on the movements in the options market lately.

Company News for Mar 12, 2024

Companies in The News Are: LEGN, BA, ALK, FTRE, AVGO.

Cognizant (CTSH), Microsoft Team Up to Streamline Healthcare

Cognizant (CTSH) and Microsoft join forces to transform healthcare admin with generative AI integration on TriZetto.

Cognizant (CTSH) Expands Gen-AI Footprint With Flowsource

Cognizant (CTSH) launches Flowsource, which expands its footprint in the growing generative AI footprint.

Cognizant (CTSH) Boosts Innovation With Microsoft AI Assistant

Cognizant (CTSH) and Microsoft's Innovation Assistant, powered by Azure OpenAI, boosts creative problem-solving in client challenges through Bluebolt.

Cognizant (CTSH) Expands Healthcare Footprint With Fortrea Deal

Cognizant (CTSH) drives Fortrea's digital journey, reshaping the CRO industry with a four-year transformative technology partnership.

Stock Market News for Nov 14, 2023

Wall Street closed mixed on Monday as market participants awaited the release of a key inflation data.

Zacks.com featured highlights include Intrepid Potash, Fortrea Holdings and Cricut

Intrepid Potash, Fortrea Holdings and Cricut are part of the Zacks Screen of the Week article.

Shrabana Mukherjee headshot

New Analysts Initiate Coverage: 3 Stocks to Watch

The recent surge in analyst coverage for stocks such as Intrepid Potash (IPI), Fortrea (FTRE) and Cricut (CRCT) indicates the potential for significant price appreciation in the near term.